Filter
371 - 380 of 1239 results
Results for
Behind HRSA’s Global HIV/AIDS Coordination
Impact Brief
HRSA program provides versatile TA for vast portfolio of HIV/AIDS Programs, furthers bidirectional US-Global learning agenda and local system strengthening for HIV services
Coordinating a National Response to COVID-19 with Homeless Service Providers
Impact Brief
Diabetes Health Card Increases Risk Awareness
Project
Changing behavior requires reaching people at the right time: when they are open to making a change. One indication of that willingness in the diabetes context is if they are searching for diabetes-related information online. The challenge is how to take…
The Ready to Work Partnership Grant Evaluation: Findings from the Interim Impact Study of Four Employment Services Programs for the Long-Term Unemployed
Publication
The RTW grantee programs increased receipt of employment-related services and credentials, but the study did not detect impact on earnings.
Design and Evaluation Principles for Children’s Savings Account Programs
Publication
Job Search Assistance (JSA) Strategies Evaluation
Project
Temporary Assistance for Needy Families (TANF) programs typically provide job search assistance (JSA) in addition to their income-support role. JSA strategies can include group, one-on-one, or self-directed activities. While there is evidence JSA…
CDC / CFA Demographic Social Comorbidities Table (DSCT)
Project
The nation’s ability to identify and respond to outbreaks relies on access to high-quality and timely data for disease surveillance.
Evaluating Australia’s Rural Primary Health Services
Project
There is clear evidence that individuals living within rural and remote areas are more likely to suffer from disease compared to metropolitan areas. The lack of health services prompted Australia’s Department of Health to implement the Rural Primary…
Evaluating the Cell and Gene Therapy Access Model
Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.